NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
NeuroPace announced FDA approval of ECoG Assistant, its first AI-driven clinician-enabled feature for the RNS System. The tool leverages a dataset of 124,450 labeled intracranial EEG records to help physicians identify ECoGs of Interest and review trends more efficiently.
Key figures
- Drug Name
- ECoG Assistant
- Training records
- 124450
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.